R
Rizwan
About Rizwan
Data last updated:
Rizwan is a Director at Roldac Pharmaceuticals Private Limited (since 2025) and Director at Doonshree Traders Private Limited (since 2025). The companies operate in Chemicals. The largest current company by reported revenue is Roldac Pharmaceuticals Private Limited at ₹2.8 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Roldac Pharmaceuticals Private Limited U24290UR2020PTC011831 | Director | 05 Dec 2025 | 2020 | ₹2.8 Lakh (FY 2023) | Active |
| Doonshree Traders Private Limited U47990UT2025PTC020326 | Director | 05 Dec 2025 | 2025 | Active |
Board colleagues of Rizwan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rubi | 11410624 | Roldac Pharmaceuticals Private Limited , Doonshree Traders Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rizwan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rizwan
Rizwan currently holds 2 directorships: Roldac Pharmaceuticals Private Limited (Director, since 05 Dec 2025, revenue ₹2.8 Lakh (FY 2023)); Doonshree Traders Private Limited (Director, since 05 Dec 2025).
Rizwan was first appointed on 05 Dec 2025 as Director at Roldac Pharmaceuticals Private Limited.
The current boards of Rizwan's companies include Rubi (Roldac Pharmaceuticals Private Limited).